Covington Capital Management reports 9.75% increase in ownership of MRK / Merck & Co., Inc.
August 13, 2018 - Covington Capital Management has filed a 13F-HR form disclosing ownership of 198,799 shares of Merck & Co., Inc. (NYSE:MRK) with total holdings valued at $12,067,000 USD as of June 30, 2018. Covington Capital Management had filed a previous 13F-HR on May 11, 2018 disclosing 181,139 shares of Merck & Co., Inc. at a value of $9,867,000 USD. This represents a change in shares of 9.75 percent and a change in value of 22.30 percent during the quarter.
Other investors with positions similar to Covington Capital Management include Davy Asset Management Ltd, Godsey & Gibb Associates, Varma Mutual Pension Insurance Co, People's United Financial, Inc., Central Securities Corp, and Boston Common Asset Management, LLC.
Merck & Co., Inc. has declared a standard industrial code (sic) of 2834 which is the "Pharmaceutical Preparations" industry. Covington Capital Management's top industries are "Construction Special Trade Contractors" (sic 17), "Non-depository Credit Institutions" (sic 61), and "Food Stores" (sic 54).
The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.
In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.
Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.
as of ET